Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]
Sallam TA +6 more
europepmc +1 more source
Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]
Wang X +11 more
europepmc +1 more source
Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature. [PDF]
Malakar S +14 more
europepmc +1 more source
Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]
Jafari M +5 more
europepmc +1 more source
Enhanced information cross-attention fusion for drug-target binding affinity prediction. [PDF]
Fei A +5 more
europepmc +1 more source
Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]
AlKaabi H +4 more
europepmc +1 more source
Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]
Mustafa A +6 more
europepmc +1 more source
Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice. [PDF]
Mattos M +20 more
europepmc +1 more source
Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients With Prior DAA Failure: A Retrospective Study From a National Treatment Center. [PDF]
Singh S +6 more
europepmc +1 more source
Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt. [PDF]
Garcia-Cehic D +12 more
europepmc +1 more source

